MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-UP-50-0060617
Sumit Pharmaceuticals Private Limited
Sumit Pharmaceuticals Private Limited - pharma in Lucknow, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹24.86 Cr
▲ 34% YoY
Net profit · FY 2025
₹52.01 Lakh
Net margin 2.1%
EBITDA · FY 2025
₹71.39 Lakh
EBITDA margin 2.9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹2.38 Lakh
Issued & subscribed
Open charges
₹1.22 Cr
Secured borrowings
Company age
40 yrs
Est. 1986
Directors on board
2
As per MCA filings
About Sumit Pharmaceuticals Private Limited
Data last updated:
Sumit Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 July 1986 and has been in existence for over 40 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U29297UP1986PTC008040. Its GSTIN is 09AABCS7595L1ZK (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2.38 Lakh. It is led by directors Sanjeev Agarwal (Whole-Time Director) and Anshu Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 6 Ugf Kulbhasker Complex 78 Gautam Budh Marg Lucknow, Uttar Pradesh, India – 226018.
As per the financials filed for FY 2025, the company reported a revenue of ₹24.86 Cr, a growth of 34% compared to the previous year. For the same year it recorded a net profit of ₹52.01 Lakh (net margin 2.1%) and EBITDA of ₹71.39 Lakh (EBITDA margin 2.9%). Revenue has grown at a compounded annual rate (CAGR) of 31% over three years and 22% over five years.
As per MCA filings, the company has open charges of ₹1.22 Cr on record.
Sumit Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0060617). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Sumit Pharmaceuticals Private Limited
CIN U29297UP1986PTC008040
Registration Number 008040
Incorporation Date 17 July 1986
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UP-50-0060617
Recognitions & Rankings of Sumit Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressB – 6 Ugf Kulbhasker Complex 78 Gautam Budh Marg Lucknow, Uttar Pradesh, India – 226018
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Sumit Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Sumit Pharmaceuticals Private Limited
The main business activity of Sumit Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Sumit Pharmaceuticals Private Limited FY 2025 filings available
Sumit Pharmaceuticals Private Limited reported revenue of ₹24.86 Cr (up 34% YoY) for FY 2025.
Revenue · FY 2025
₹24.86 Cr ▲ 34%
Net profit · FY 2025
₹52.01 Lakh margin 2.1%
EBITDA · FY 2025
₹71.39 Lakh margin 2.9%
Compounded Annual Growth Rate (CAGR) of Sumit Pharmaceuticals Private Limited
Revenue CAGR growth
1 year
▲ 34%
3 years · compounded
▲ 31%
5 years · compounded
▲ 22%
EBITDA CAGR growth
1 year
▲ 37%
3 years · compounded
▲ 36%
5 years · compounded
▲ 28%
Revenue has grown at a compounded annual rate (CAGR) of 22% over five years, including 34% growth in the latest year. EBITDA rose 37% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Sumit Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹71.39 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹52.01 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Sumit Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Sumit Pharmaceuticals are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Sumit Pharmaceuticals Private Limited
Sumit Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjeev Agarwal | Whole-Time Director | 23 May 1992 | 34 Years 4 Months | Current |
| Anshu Agarwal | Director | 27 Dec 2010 | 15 Years 9 Months | Current |
Peer Comparison of Sumit Pharmaceuticals Private Limited
Sumit Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anthus Pharmaceuticals Private Limited | ₹24.97 Cr (FY 2024) | •••• | •••• | 4.0% | •••• | Chennai, Tamil Nadu, India |
| Thrift Pharmaceuticals Private Limited | ₹24.95 Cr (FY 2024) | •••• | •••• | 11.0% | •••• | Vadodara, Gujarat, India |
| Eucare Pharmaceuticals P Ltd | ₹24.93 Cr (FY 2024) | •••• | •••• | 31.0% | •••• | Tamil Nadu, India |
| Pyxus Pharmaceuticals Private Limited | ₹24.91 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Ahmedabad, Gujarat, India |
| Artura Pharmaceuticals Private Limited | ₹24.89 Cr (FY 2024) | •••• | •••• | 37.0% | •••• | Chennai, Tamil Nadu, India |
| Sumit Pharmaceuticals Private Limited this company | ₹24.86 Cr (FY 2025) | •••• | •••• | 34.0% | •••• | Lucknow, Uttar Pradesh, India |
| Drdelight Pharmaceuticals Private Limited | ₹24.84 Cr (FY 2024) | •••• | •••• | 21192.0% | •••• | Pune, Maharashtra, India |
| Sentosa Geigy (India) Labs Limited | ₹24.79 Cr (FY 2025) | •••• | •••• | 50.0% | •••• | Delhi, India |
| Vishwakrupa Pharma Private Limited | ₹24.79 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Ratnagiri, Maharashtra, India |
| Gal Care Pharmaceuticals Private Limited | ₹24.69 Cr (FY 2024) | •••• | •••• | 16.0% | •••• | Jaipur, Rajasthan, India |
| Bankura Jyotirmoyee Pharma Private Limited | ₹24.63 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | West Bengal, India |
Peers are the five companies nearest above and the five nearest below Sumit Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Sumit Pharmaceuticals Private Limited
Sumit Pharmaceuticals Private Limited is audited by A SACHDEV & CO for the financial year 2018.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| A SACHDEV & CO | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Sumit Pharmaceuticals Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Sumit Pharmaceuticals Private Limited
Open charges
₹1.22 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Sep 2025 | Others | ₹12 Lakh | Open |
| 28 Jun 2012 | Union Bank of India | ₹10 Lakh | Open |
| 21 Jan 2011 | Others | ₹1 Cr | Open |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Sumit Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Sumit Pharmaceuticals.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Sumit Pharmaceuticals Private Limited
Sumit Pharmaceuticals Private Limited has 3 board changes on record since 1992: 2 appointments and 1 cessation. The latest: Anshu Agarwal was appointed as Director on 27 Dec 2010.
AGM
Sumit Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 12.00 Lakh with Charge ID 101200295 was registered on 22 Sep 2025.
Filing
Sumit Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh I.
Charges
A charge with Others of Rs. 100.00 Lakh registered on 21 Jan 2011 with Charge ID 10265588 was modified on 27 Feb 2023.
Charges
A charge with Union Bank Of India amounted to Rs. 10.00 Lakh with Charge ID 100795386 was registered on 28 Jun 2012.
Charges
A charge with Others amounted to Rs. 100.00 Lakh with Charge ID 10265588 was registered on 21 Jan 2011.
Appointed
Anshu Agarwal was appointed as Director.
Ceased
Indu Vij ceased to be Director.
Appointed
Sanjeev Agarwal was appointed as Whole-Time Director.
Incorporation
17 Jul 1986
Sumit Pharmaceuticals Private Limited was registered on 17 Jul 1986 with Roc Uttar Pradesh I & aged 40 years 3 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Sumit Pharmaceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Sumit Pharmaceuticals Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Sumit Pharmaceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Sumit Pharmaceuticals Private Limited
Sumit Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AABCS7595L1ZK | Uttar Pradesh | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Sumit Pharmaceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sumit Pharmaceuticals Private Limited
Sumit Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 July 1986 (40+ years old) and is registered under CIN U29297UP1986PTC008040.
Sumit Pharmaceuticals reported revenue of ₹24.86 Cr for FY 2025 (up 34% YoY).
Sumit Pharmaceuticals has 2 current directors:
- Sanjeev Agarwal - Whole-Time Director
- Anshu Agarwal - Director
Sumit Pharmaceuticals reported a net profit of ₹52.01 Lakh (net margin 2.1%) and EBITDA of ₹71.39 Lakh (EBITDA margin 2.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Sumit Pharmaceuticals is 31% over three years and 22% over five years. In the latest year (FY 2025) revenue rose 34%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Sumit Pharmaceuticals is 09AABCS7595L1ZK, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Sumit Pharmaceuticals is U29297UP1986PTC008040. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sumit Pharmaceuticals was incorporated on 17 July 1986, making it 40+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Sumit Pharmaceuticals by revenue are Anthus Pharmaceuticals Private Limited, Thrift Pharmaceuticals Private Limited, Eucare Pharmaceuticals P Ltd, Pyxus Pharmaceuticals Private Limited, Artura Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Anshu Agarwal was appointed as Director on 27 Dec 2010. Indu Vij ceased to be Director on 27 Dec 2010. Sanjeev Agarwal was appointed as Whole-Time Director on 23 May 1992.
Yes, Sumit Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-UP-50-0060617).